Drug Therapy

1. Prime time for polycystic kidney disease: does one shot of roscovitine bring the cure?

Author
Wolfgang Kuehn E; Walz G;
Institution
Renal Division, University Hospital Freiburg, Hugstetter Strasse 55, 79104 Freiburg, Germany.
Journal
Nephrol Dial Transplant. 2007 Apr 4;.

2. Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.

Author
Namli S; Oflaz H; Turgut F; Alisir S; Tufan F; Ucar A; Mercanoglu F; Ecder T;
Institution
Department of Internal Medicine, Istanbul School of Medicine, Istanbul University. Istanbul. Turkey.
Journal
Ren Fail. 2007;29(1):55-9.
Abstract URL
Click here to view abstract

3. The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.

Author
Jafar TH; Stark PC; Schmid CH; Strandgaard S; Kamper AL; Maschio G; Becker G; Perrone RD; Levey AS;
Institution
Division of Nephrology, New England Medical Center, Boston, Massachusetts, USA. tazeen.jafar@aku.edu
Journal
Kidney Int. 2005 Jan;67(1):265-71.
Abstract URL
Click here to view abstract

4. Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease?

Author
Grantham JJ;
Institution
Kansas University Medical Center, Kansas City, KS 66160, USA. jgrantha@kumc.edu
Journal
Nat Clin Pract Nephrol. 2006 Feb;2(2):66-7.

5. Do vasopressin receptor type 2 antagonists have therapeutic potential in polycystic kidney diseases?

Author
Doggrell, Sheila A;
Institution
Doggrell Biomedical Communications, Auckland, New Zealand. s_doggrell@yahoo.com
Journal
Expert Opin Investig Drugs 2004 Apr;13(4):431-4.
Abstract URL
Click here to view abstract